Press release
March 10, 2026
Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board
Odyssey Therapeutics, Inc. (ODTX)
BOSTON, March 10, 2026 — Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology, today announced